Filing Details

Accession Number:
0001415889-24-023366
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-13 16:15:20
Reporting Period:
2024-09-11
Accepted Time:
2024-09-13 16:15:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1855644 Zura Bio Ltd ZURA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1995535 Parvinder Thiara C/O Zura Bio Limited
1489 W. Warm Springs Rd. #110
Henderson NV 89014
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Disposition 2024-09-11 3,800,000 $2.70 1,001,633 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
Footnotes
  1. The shares were disposed of by way of a private transaction dated September 11, 2024.
  2. Athanor Master Fund, LP (the "Master Fund") and Athanor International Master Fund, LP (the "International Master Fund", and together with the Master Fund, the "Funds") are the direct holders of the securities reported herein. Athanor Capital Partners, LP ("Master GP") is the general partner of the Master Fund. Athanor Capital Partners GP, LLC ("ACP GP") is the general partner of Master GP. Athanor International Fund GP, LP ("International Master GP") is the general partner of the International Master Fund. Athanor International Fund Ultimate GP, LLC ("AIFU GP") is the general partner of International Master GP. Athanor Capital, LP ("Athanor Capital") is the investment adviser to the Funds. Athanor Capital GP, LLC ("Athanor Capital GP") is the general partner of Athanor Capital. Parvinder Thiara is the managing member of Athanor Capital GP, AIFU GP and ACP GP.
  3. By virtue of the foregoing relationships, Mr. Thiara and each of the entities named in footnote 2 above may be deemed to beneficially own the securities held by the Funds, however each of them disclaims beneficial ownership of such securities, except to the extent of his or its pecuniary interest therein.